These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


229 related items for PubMed ID: 15000764

  • 1. Glycemic parameters with multiple daily injections using insulin glargine versus insulin pump.
    Garg SK, Walker AJ, Hoff HK, D'Souza AO, Gottlieb PA, Chase HP.
    Diabetes Technol Ther; 2004 Feb; 6(1):9-15. PubMed ID: 15000764
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine.
    Doyle EA, Weinzimer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane WV.
    Diabetes Care; 2004 Jul; 27(7):1554-8. PubMed ID: 15220227
    [Abstract] [Full Text] [Related]

  • 6. Flexible insulin therapy with glargine insulin improved glycemic control and reduced severe hypoglycemia among preschool-aged children with type 1 diabetes mellitus.
    Alemzadeh R, Berhe T, Wyatt DT.
    Pediatrics; 2005 May; 115(5):1320-4. PubMed ID: 15867042
    [Abstract] [Full Text] [Related]

  • 7. Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.
    Imbergamo MP, Amato MC, Sciortino G, Gambina M, Accidenti M, Criscimanna A, Giordano C, Galluzzo A.
    Clin Ther; 2008 Aug; 30(8):1476-84. PubMed ID: 18803989
    [Abstract] [Full Text] [Related]

  • 8. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes.
    Hanaire-Broutin H, Melki V, Bessières-Lacombe S, Tauber JP.
    Diabetes Care; 2000 Sep; 23(9):1232-5. PubMed ID: 10977011
    [Abstract] [Full Text] [Related]

  • 9. Effect of continuous subcutaneous insulin infusion vs multiple daily insulin injection with glargine as basal insulin: an open parallel long-term study.
    Lepore G, Dodesini AR, Nosari I, Trevisan R.
    Diabetes Nutr Metab; 2004 Apr; 17(2):84-9. PubMed ID: 15244099
    [Abstract] [Full Text] [Related]

  • 10. The DURAbility of Basal versus Lispro mix 75/25 insulin Efficacy (DURABLE) trial: comparing the durability of lispro mix 75/25 and glargine.
    Buse JB, Wolffenbuttel BH, Herman WH, Hippler S, Martin SA, Jiang HH, Shenouda SK, Fahrbach JL.
    Diabetes Care; 2011 Feb; 34(2):249-55. PubMed ID: 21270182
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment.
    Lepore G, Dodesini AR, Nosari I, Trevisan R.
    Diabetes Care; 2003 Apr; 26(4):1321-2. PubMed ID: 12663625
    [No Abstract] [Full Text] [Related]

  • 13. Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII.
    Hirsch IB, Bode BW, Garg S, Lane WS, Sussman A, Hu P, Santiago OM, Kolaczynski JW, Insulin Aspart CSII/MDI Comparison Study Group.
    Diabetes Care; 2005 Mar; 28(3):533-8. PubMed ID: 15735183
    [Abstract] [Full Text] [Related]

  • 14. Basal insulin substitution with glargine or continuous subcutaneous insulin infusion in adult type 1 diabetes patients-a randomized controlled trial.
    Bragd J, von Döbeln A, Lins PE, Adamson U, Bergström J, Oskarsson P.
    Diabetes Technol Ther; 2010 Sep; 12(9):689-93. PubMed ID: 20687863
    [Abstract] [Full Text] [Related]

  • 15. Feasibility of continuous subcutaneous insulin infusion and daily supplemental insulin glargine injection in children with type 1 diabetes.
    Alemzadeh R, Parton EA, Holzum MK.
    Diabetes Technol Ther; 2009 Aug; 11(8):481-6. PubMed ID: 19698060
    [Abstract] [Full Text] [Related]

  • 16. Reduced severe hypoglycemia with insulin glargine in intensively treated adults with type 1 diabetes.
    Garg SK, Paul JM, Karsten JI, Menditto L, Gottlieb PA.
    Diabetes Technol Ther; 2004 Oct; 6(5):589-95. PubMed ID: 15628812
    [Abstract] [Full Text] [Related]

  • 17. Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine Hagedorn insulin.
    Chase HP, Dixon B, Pearson J, Fiallo-Scharer R, Walravens P, Klingensmith G, Rewers M, Garg SK.
    J Pediatr; 2003 Dec; 143(6):737-40. PubMed ID: 14657818
    [Abstract] [Full Text] [Related]

  • 18. The Impact of Continuous Subcutaneous Insulin Infusion Therapy on Efficacy and Safety in a Cohort of Type 1 Diabetes Patients: A 3-Year Prospective Study.
    Melidonis A, Kamaratos A, Angelidi A, Thomakos P, Vrakas S, Bakalis J, Fousteris E, Iraklianou S.
    Diabetes Technol Ther; 2016 Mar; 18(3):159-63. PubMed ID: 26862678
    [Abstract] [Full Text] [Related]

  • 19. Glycemic Control in Adult Type 1 Diabetes Patients with Insulin Glargine, Insulin Detemir, or Continuous Subcutaneous Insulin Infusion in Daily Practice.
    Rautiainen P, Tirkkonen H, Laatikainen T.
    Diabetes Technol Ther; 2018 May; 20(5):363-369. PubMed ID: 29741925
    [Abstract] [Full Text] [Related]

  • 20. Comparison of insulin aspart with buffered regular insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes.
    Bode B, Weinstein R, Bell D, McGill J, Nadeau D, Raskin P, Davidson J, Henry R, Huang WC, Reinhardt RR.
    Diabetes Care; 2002 Mar; 25(3):439-44. PubMed ID: 11874927
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.